MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.
SMU students advance to global ICT finals
Sefako Makgatho Health Sciences University (SMU) has once again demonstrated its growing impact in science and innovation, as a team of three final-year Mathematical Science students secured top honours at the Huawei ICT Competition Regional Finals. The winning...
